Latest Parkinson's Disease Foundation Stories
-- DUOPA is the first and only treatment providing 16 continuous hours of carbidopa and levodopa for motor fluctuations in advanced Parkinson's disease NORTH CHICAGO, Ill., Jan.
New program will support the identification of novel drug targets to treat Parkinson's disease MOUNTAIN VIEW, Calif., Jan.
Recognizes "All the Ways Care Partners Care" During November's National Family Caregivers Month NEW YORK, Nov.
Collaboration to Expand Pioneering Education Program NEW YORK, Oct. 30, 2014 /PRNewswire-USNewswire/ -- The Parkinson's Disease Foundation® (PDF®) and the Edmond J.
Free Educational Seminars, Designed with Community Input, Provide Practical Tips for People with Parkinson's and Continuing Education for Health Professionals NEW YORK, Sept.
GRAND RAPIDS, Mich., Aug.
FPRT Bio works closely with academic leaders and research organizations to advance the use of XPro1595 in the treatment of Parkinson’s disease. Dallas, Texas
More Than 30 Scientific Projects Chosen for Potential to Improve the Lives and Futures of People Touched by Parkinson's NEW YORK, July 24, 2014 /PRNewswire-USNewswire/ -- The Parkinson's
100% of donations raised will go to research KINGSTON, N.J., July 22, 2014 /PRNewswire-USNewswire/ -- Over 11,000 people from across the country came together on Saturday, April 26(th)
Initiative to optimize patient care spearheaded by AbbVie and The Michael J.
- A political dynamiter.